<DOC>
	<DOC>NCT01367548</DOC>
	<brief_summary>A double-blind, randomized, parallel-group study designed to evaluate the safety and activity of IV MNTX in the treatment of Post-Operative Ileus (POI) in patients who underwent segmental colectomies via laparotomy.</brief_summary>
	<brief_title>Intravenous (IV) Methylnaltrexone (MNTX) in the Prevention of Post-Operative Ileus</brief_title>
	<detailed_description />
	<mesh_term>Ileus</mesh_term>
	<mesh_term>Methylnaltrexone</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>1. Males and females, 18 yrs or older 2. Patients who have undergone a segmental colectomy 3. Must be receiving opioids via IV. 1. Patients who received any experimental drug in the last 30 days 2. Patients receiving spinal medication for postoperative pain relief 3. Patients who have undergone operations for complications related to inflammatory bowel disease 4. Patients with recent history of abdominal radiation therapy.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>